Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-15

Clinical Trial Update: Valproate Versus Topiramate in Migraine [Phase 3]

View source ↗

Summary

A Phase 3 trial sponsored by Kafrelsheikh University comparing valproate to topiramate for migraine has completed (status COMPLETED).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topiramate (Topiramate)
  • Valproate (valproate)

Snippet

Sponsor: Kafrelsheikh University | Conditions: Migraine Disorders | Phase 3 | Status: COMPLETED